Anti–tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease
…, S Bressman, A Park, C Lu, N Chen… - JAMA …, 2018 - jamanetwork.com
Importance Despite established genetic and pathophysiologic links between inflammatory
bowel disease (IBD) and Parkinson disease (PD), clinical data supporting this association …
bowel disease (IBD) and Parkinson disease (PD), clinical data supporting this association …
Adalimumab induces deep remission in patients with Crohn's disease
…, PF Pollack, RB Thakkar, AM Robinson, N Chen… - Clinical …, 2014 - Elsevier
Background & Aims Patients with moderate to severe ileocolonic Crohn's disease (CD) who
received adalimumab induction and maintenance therapy had greater rates of mucosal …
received adalimumab induction and maintenance therapy had greater rates of mucosal …
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis
…, A Lazar, RB Thakkar, B Huang, N Reilly, N Chen… - Gastroenterology, 2014 - Elsevier
Background & Aims Adalimumab is effective for induction and maintenance of remission in
patients with moderate to severe ulcerative colitis (UC). We assessed whether adalimumab, …
patients with moderate to severe ulcerative colitis (UC). We assessed whether adalimumab, …
13C NMR Study of Halogen Bonding of Haloarenes: Measurements of Solvent Effects and Theoretical Analysis
R Glaser, N Chen, H Wu, N Knotts… - Journal of the American …, 2004 - ACS Publications
… Naijun Chen … Naijun Chen - Contribution from the Department of Chemistry, University
of Missouri, Columbia, Missouri, 65211, and Institut für Anorganische Chemie, Universität …
of Missouri, Columbia, Missouri, 65211, and Institut für Anorganische Chemie, Universität …
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to …
…, D Binion, K McHugh, S Alam, N Chen… - Canadian Journal of …, 2011 - hindawi.com
OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula
healing, patient-reported outcomes and safety in Canadian patients with moderate to severe …
healing, patient-reported outcomes and safety in Canadian patients with moderate to severe …
Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 trials
Importance Adalimumab was recently approved for the treatment of noninfectious intermediate
uveitis, posterior uveitis, and panuveitis. Objective To assess the effect of adalimumab on …
uveitis, posterior uveitis, and panuveitis. Objective To assess the effect of adalimumab on …
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work …
D van der Heijde, A Joshi, AL Pangan, N Chen… - …, 2016 - academic.oup.com
Objective. To assess the impact of achieving Assessment in SpondyloArthritis international
Society 40% (ASAS40) response or an Ankylosing Spondylitis Disease Activity Score inactive …
Society 40% (ASAS40) response or an Ankylosing Spondylitis Disease Activity Score inactive …
Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study
V Strand, AM Rentz, MA Cifaldi, N Chen… - The Journal of …, 2012 - jrheum.org
Objective. Rheumatoid arthritis (RA) is associated with significant impairments in health-related
quality of life (HRQOL). We evaluated patient-reported outcomes including HRQOL …
quality of life (HRQOL). We evaluated patient-reported outcomes including HRQOL …
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control …
…, MB Goldring, B Guérette, MA Cifaldi, N Chen… - Annals of the …, 2013 - ard.bmj.com
Objectives Tumour necrosis factor inhibition plus methotrexate is believed to inhibit
radiographic progression independent of inflammation. This analysis assessed whether these …
radiographic progression independent of inflammation. This analysis assessed whether these …
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for …
…, MP Luo, P Wordsworth, RL Wong, N Chen… - The Journal of …, 2008 - jrheum.org
Objective To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients
with active ankylosing spondylitis (AS). Methods The Adalimumab Trial Evaluating Long-Term …
with active ankylosing spondylitis (AS). Methods The Adalimumab Trial Evaluating Long-Term …